^
    7ms
    DODEKA: Safety and Early Signs of Efficacy of IL12-L19L19. (clinicaltrials.gov)
    P1, N=94, Recruiting, Philogen S.p.A. | Trial completion date: Dec 2023 --> Dec 2025 | Trial primary completion date: Dec 2023 --> Dec 2025
    Trial completion date • Trial primary completion date
    |
    dodekin (F8-IL12)
    over2years
    DODEKA: Safety and Early Signs of Efficacy of IL12-L19L19. (clinicaltrials.gov)
    P1, N=94, Recruiting, Philogen S.p.A. | Trial completion date: Jun 2022 --> Jun 2023 | Trial primary completion date: Jun 2022 --> Jun 2023
    Trial completion date • Trial primary completion date
    |
    MSI (Microsatellite instability)
    |
    MSI-H/dMMR
    |
    dodekin (F8-IL12)
    over4years
    DODEKA: Safety and Early Signs of Efficacy of IL12-L19L19. (clinicaltrials.gov)
    P1, N=94, Recruiting, Philogen S.p.A.
    Clinical • New P1 trial
    |
    MSI (Microsatellite instability)
    |
    MSI-H/dMMR
    |
    dodekin (F8-IL12)